Cargando…
Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
Cystic fibrosis (CF) is an autosomal recessive disorder, caused by genetic mutations in CF transmembrane conductance regulator protein. Several reports have indicated the presence of specific fatty acid alterations in CF patients, most notably decreased levels of plasmatic and tissue docosahexaenoic...
Autores principales: | Teopompi, Elisabetta, Risé, Patrizia, Pisi, Roberta, Buccellati, Carola, Aiello, Marina, Pisi, Giovanna, Tripodi, Candida, Fainardi, Valentina, Clini, Enrico, Chetta, Alfredo, Rovati, G. Enrico, Sala, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716427/ https://www.ncbi.nlm.nih.gov/pubmed/31507425 http://dx.doi.org/10.3389/fphar.2019.00938 |
Ejemplares similares
-
Short-Term Effects of High-Frequency Chest Compression and Positive Expiratory Pressure in Patients With Cystic Fibrosis
por: Fainardi, Valentina, et al.
Publicado: (2011) -
Docosahexaenoic and Arachidonic Acids as Neuroprotective Nutrients throughout the Life Cycle
por: Sambra, Verónica, et al.
Publicado: (2021) -
Maternal Supply of Both Arachidonic and Docosahexaenoic Acids Is Required for Optimal Neurodevelopment
por: Basak, Sanjay, et al.
Publicado: (2021) -
Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants
por: Hellström, Ann, et al.
Publicado: (2021) -
Age Stratification and Impact of Eicosapentaenoic Acid and Docosahexaenoic Acid to Arachidonic Acid Ratios in Ischemic Stroke Patients
por: Ueno, Yuji, et al.
Publicado: (2018)